Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	312.76	139.04	143.94	87.88	149.1	251.25
Cash & Short-Term Investments	312.76	139.04	143.94	87.88	149.1	251.25
Cash Growth	81.06%	-3.41%	63.79%	-41.06%	-40.66%	-
Prepaid Expenses	0.5	1.36	1.09	2.51	3.87	3.83
Restricted Cash	0.45	0.45	0.45	-	-	-
Other Current Assets	2.56	1.28	4.39	6.03	6.63	2.79
Total Current Assets	316.26	142.13	149.87	96.42	159.6	257.88
Property, Plant & Equipment	14.73	15.87	20.41	25.91	50.61	0.29
Other Long-Term Assets	2.34	2.37	2.46	3.95	3.74	0.72
Total Assets	333.33	160.36	172.73	126.28	213.96	258.88
Accounts Payable	7.71	3.59	6.37	10.95	21.76	1.99
Accrued Expenses	9	9.59	9.46	14.04	25.85	4.87
Current Portion of Leases	1.74	1.88	1.65	1.52	-	-
Current Unearned Revenue	5.49	9.77	18.11	33.56	-	-
Other Current Liabilities	1.41	1.4	1.18	2.73	4.14	0.26
Total Current Liabilities	25.35	26.23	36.76	62.79	51.75	7.13
Long-Term Debt	41.05	43.94	40.51	37.97	37.19	-
Long-Term Leases	16.98	17.74	18.95	20.44	25.9	-
Other Long-Term Liabilities	1.23	0.93	1.58	4.13	3.74	0.45
Total Liabilities	84.6	88.84	97.79	125.33	118.57	7.58
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	900.14	677.86	587.94	402.39	331.03	312.43
Retained Earnings	-650.72	-602.31	-513.01	-401.44	-235.65	-61.13
Comprehensive Income & Other	-0.7	-4.03	-	-	-	-
Shareholders' Equity	248.73	71.53	74.94	0.95	95.38	251.3
Total Liabilities & Equity	333.33	160.36	172.73	126.28	213.96	258.88
Total Debt	59.76	63.56	61.11	59.93	63.09	-
Net Cash (Debt)	253	75.48	82.83	27.95	86.01	251.25
Net Cash Growth	121.07%	-8.88%	196.34%	-67.50%	-65.77%	-
Net Cash Per Share	0.92	0.30	0.71	0.64	2.28	14.22
Filing Date Shares Outstanding	272.79	205	187.02	63.47	38.47	37.76
Total Common Shares Outstanding	272.73	204.94	186.96	63.21	38.47	37.76
Working Capital	290.92	115.9	113.11	33.63	107.86	250.75
Book Value Per Share	0.91	0.35	0.40	0.02	2.48	6.65
Tangible Book Value	248.73	71.53	74.94	0.95	95.38	251.3
Tangible Book Value Per Share	0.91	0.35	0.40	0.02	2.48	6.65
Machinery	4.72	4.7	4.87	4.88	3.04	0.1
Construction In Progress	4.22	4.25	6.82	9.63	46	0.2
Leasehold Improvements	2.12	2.12	2.12	2.09	2.07	-

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q